The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.
Iran: In patients undergoing noncardiac surgery (NCS), determining the risk of postoperative cardiovascular (CV) complications is fundamental to every preoperative assessment.Results from a recent.